Oppenheimer initiated coverage of Amrize with a rating of Outperform and set a new price target of $62.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/9/2025 | $62.00 | Outperform | Oppenheimer |
| 7/15/2025 | $57.00 | Overweight | Analyst |
| 7/10/2025 | $62.00 | Outperform | Bernstein |
| 7/1/2025 | $57.00 | Neutral | Goldman |
| 6/30/2025 | Buy | Erste Group | |
| 6/30/2025 | $52.50 | Hold | Jefferies |
| 6/30/2025 | $64.00 | Buy | Berenberg |
| 6/26/2025 | $56.00 | Neutral | BofA Securities |
SCHEDULE 13G - Amrize Ltd (0002035989) (Subject)
10-Q - Amrize Ltd (0002035989) (Filer)
8-K - Amrize Ltd (0002035989) (Filer)
4 - Amrize Ltd (0002035989) (Issuer)
4 - Amrize Ltd (0002035989) (Issuer)
4 - Amrize Ltd (0002035989) (Issuer)
Amrize Ltd (NYSE:AMRZ) has received a notice of an unsolicited "mini-tender" offer by TRC Capital Investment Corporation ("TRC") to purchase up to 2,000,000 ordinary shares, $0.01 par value per share (the "Ordinary Shares") of Amrize at a price of $49.63 per Ordinary Share in cash. The offer represents less than 1.0% of the outstanding Ordinary Shares. TRC's offer price is 4.48% less than the $51.96 closing price per Ordinary Share on August 26, 2025, the last trading day before the mini-tender offer commenced. Amrize does not endorse TRC's unsolicited mini-tender offer and recommends that Amrize shareholders do not tender their Ordinary Shares in the offer because the offer is at a pri
Successful spin-off and listing of Amrize on the NYSE and SIX on June 23 Resilient Q2 results with strong margins show strength of the business and market positions Launched ASPIRE program to drive $250M+ in synergies and accelerate margin expansion Investing for growth with CapEx and M&A; acquired operations of Langley Concrete Group, Inc. Established investment-grade balance sheet with substantial financial firepower Well positioned to capitalize on long-term, profitable growth within a $200B+ addressable market Amrize (AMRZ) announced today its second quarter 2025 financial results. Jan Jenisch, Chairman and CEO: "We successfully listed Amrize on the NYSE and SIX on
Amrize (NYSE:AMRZ) will publish its second quarter 2025 financial results after the U.S. market closes on Wednesday, August 6, 2025, followed by a webcast to discuss the company's financial results at 9:00 am Eastern Time on Thursday, August 7, 2025. Registration for the Q2 2025 live webcast can be completed at https://amrize-quarterly-results-q2-2025.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in the events section of www.amrize.com/investors. A replay and transcript will be available at the same location following the webcast. About Amrize Amrize (NYSE:AMRZ) is building North America, as the partner of choice for professiona
Oppenheimer initiated coverage of Amrize with a rating of Outperform and set a new price target of $62.00
Analyst initiated coverage of Amrize with a rating of Overweight and set a new price target of $57.00
Bernstein initiated coverage of Amrize with a rating of Outperform and set a new price target of $62.00
4 - Amrize Ltd (0002035989) (Issuer)
4 - Amrize Ltd (0002035989) (Issuer)
4 - Amrize Ltd (0002035989) (Issuer)
Amrize (NYSE:AMRZ) will publish its second quarter 2025 financial results after the U.S. market closes on Wednesday, August 6, 2025, followed by a webcast to discuss the company's financial results at 9:00 am Eastern Time on Thursday, August 7, 2025. Registration for the Q2 2025 live webcast can be completed at https://amrize-quarterly-results-q2-2025.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in the events section of www.amrize.com/investors. A replay and transcript will be available at the same location following the webcast. About Amrize Amrize (NYSE:AMRZ) is building North America, as the partner of choice for professiona